Researchers found that hepatocellular carcinoma surveillance was underutilized among approximately 80% of patients with cirrhosis.
The accelerated approval was based on data from two phase 2 trials: the ROAR basket study and the NCI-MATCH Subprotocol H study.
The risk for kidney failure requiring renal replacement therapy varies by cancer type, with multiple myeloma associated with the highest risk.
The effect of compliance with ERAS protocols on postoperative adverse events and length of hospital stay was evaluated in a single-center cohort study.
[Journal of Hepatocellular Carcinoma] Researchers at UT MD Anderson Cancer Center assessed the value of chest, abdominal, and pelvic CT in the surveillance of patients with HCC, and the potential drawbacks to the practice.